Ridker, Paul M

Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism

Sapkota, Y., Steinthorsdottir, V., Morris, A. P., Fassbender, A., Rahmioglu, N., De Vivo, I., Buring, J. E., Zhang, F., Edwards, T. L., Jones, S., et al. (2017) · Nature Communications

Endometriosis Research and TreatmentGenetic Associations and Epidemiology

Cited by 344

Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women

Paré, G., Chasman, D. I., Kellogg, M., Zee, R. Y. L., Rifai, N., Badola, S., Miletich, J. P., & Ridker, P. M. (2008) · PLoS Genetics

Genetic Associations and EpidemiologyBlood groups and transfusion

Cited by 341

Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

Chasman, D. I., Paré, G., Mora, S., Hopewell, J. C., Peloso, G., Clarke, R., Cupples, L. A., Hamsten, A., Kathiresan, S., Mälarstig, A., et al. (2009) · PLoS Genetics

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 337

Genetic evidence of assortative mating in humans

Robinson, M. R., Kleinman, A., Graff, M., Vinkhuyzen, A. A. E., Couper, D., Miller, M. B., Peyrot, W. J., Abdellaoui, A., Zietsch, B. P., Nolte, I. M., et al. (2017) · Nature Human Behaviour

Genetic Associations and EpidemiologyGenetic and phenotypic traits in livestock

Cited by 326

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 319

Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells

Frodermann, V., Rohde, D., Courties, G., Severe, N., Schloss, M. J., Amatullah, H., McAlpine, C. S., Cremer, S., Hoyer, F. F., Ji, F., et al. (2019) · Nature Medicine

Hematopoietic Stem Cell TransplantationExercise and Physiological Responses

Cited by 292

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit

Ridker, P. M. (2004) · American Heart Journal

Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease Prognosis

Cited by 290

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.

Ridker, P. M., Manson, J. E., Buring, J. E., Muller, J. E., & Hennekens, C. H. (1990) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 285

Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial

Chasman, D. I., Giulianini, F., MacFadyen, J., Barratt, B. J., Nyberg, F., & Ridker, P. M. (2012) · Circulation: Cardiovascular Genetics

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 285

LDL cholesterol: controversies and future therapeutic directions

Ridker, P. M. (2014) · The Lancet

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 274

Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: Implications for longevity

Ridker, P. M. (2007) · Nutrition Reviews

Inflammatory Biomarkers in Disease PrognosisNutritional Studies and Diet

Cited by 264

Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events

Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2006) · Circulation

Health disparities and outcomesCardiovascular Health and Risk Factors

Cited by 262

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Ridker, P. M. (2019) · Circulation Research

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 260

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy

Pradhan, A. D., Aday, A. W., Rose, L. M., & Ridker, P. M. (2018) · Circulation

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 258

Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events

Mora, S., Buring, J. E., & Ridker, P. M. (2014) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 255

Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

Engler, M. M., Engler, M. B., Malloy, M. J., Chiu, E. Y., Schloetter, M. C., Paul, S. M., Stuehlinger, M., Lin, K. Y., Cooke, J. P., Morrow, J. D., et al. (2003) · Circulation

Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Cited by 253

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial

Glynn, R. J., Koenig, W., Nordestgaard, B. G., Shepherd, J., & Ridker, P. M. (2010) · Annals of Internal Medicine

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 252

KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference

Schumann, G., Liu, C., O’Reilly, P., Gao, H., Song, P., Xu, B., Ruggeri, B., Amin, N., Jia, T., Preis, S., et al. (2016) · Proceedings of the National Academy of Sciences

Fibroblast Growth Factor ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 241

Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin

Hsia, J., MacFadyen, J. G., Monyak, J., & Ridker, P. M. (2011) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 231

Glycated hemoglobin measurement and prediction of cardiovascular disease

Di Angelantonio, E., Gao, P., Khan, H., Butterworth, A. S., Wormser, D., Kaptoge, S., Kondapally Seshasai, S. R., Thompson, A., Sarwar, N., Willeit, P., et al. (2014) · JAMA

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 231

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

Mangravite, L. M., Engelhardt, B. E., Medina, M. W., Smith, J. D., Brown, C. D., Chasman, D. I., Mecham, B. H., Howie, B., Shim, H., Naidoo, D., et al. (2013) · Nature

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 224

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Lindström, S., Wang, L., Smith, E. N., Gordon, W., van Hylckama Vlieg, A., de Andrade, M., Brody, J. A., Pattee, J. W., Haessler, J., Brumpton, B. M., et al. (2019) · Blood

Genetic Associations and EpidemiologyBlood Coagulation and Thrombosis Mechanisms

Cited by 223

Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events

Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., & Kwiatkowski, D. J. (2005) · Annals of Human Genetics

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 220

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease

Ridker, P. M. (2009) · Clinical Chemistry

Biomarkers in Disease MechanismsLipoproteins and Cardiovascular Health

Cited by 206